The Centers for Medicare & Medicaid Innovation launched the Bundled Payments for Care Improvement (BPCI) Initiative in 2013, 1 a voluntary alternative payment model that holds participating hospitals, practices, or facilities accountable for quality and costs in 30-, 60-, or 90-day episodes of care. Participants can join for as many or as few of 48 eligible conditions as they wish and drop out without penalty. If cost targets are achieved, participants keep a portion of the savings; if cost targets are exceeded, participants reimburse Medicare a portion of the difference.
To our knowledge, no published data characterize participation or dropout from the risk-bearing phase of this program. Such information is important because voluntary alternative payment models are a key element in Medicare's strategy to improve quality and costs of care. 2 Methods | We evaluated model 2, which includes inpatient and post-acute spending and is the track selected by more than 99% of hospitals in BCPI. Hospitals could enroll for any of 48 con-ditions beginning in October 2013. We obtained quarterly public data sets from Medicare covering January 2014 through January 2017, which list participating hospitals and their planned end dates. Dropouts were defined as hospitals that initiated participation but were absent from participant lists prior to their planned end date. Hospital characteristics were obtained from the 2014 American Hospital Association Annual Survey Database.
Wilcoxon, χ 2 , and t tests were used to compare participating hospitals with nonparticipating hospitals. Adjusted odds ratios (aORs) of dropout were calculated for hospitalcondition pairs using logistic regression with clustering by hospital. Kaplan-Meier calculations were used to estimate time to dropout, censoring hospitals still active as of January 2017.
Analyses were conducted using SAS (SAS Institute), version 9.4. Two-tailed P values less than .05 were considered statistically significant.
Results | As of January 2017, 422 hospitals had signed up for BPCI model 2 (12.0% of 3523 eligible hospitals) for a mean of 7.2 conditions (SD, 9.6), yielding 3042 hospital-condition pairs (number of hospitals × number of conditions per hospital). Participating hospitals were more often nonprofit, urban, members of a system, and teaching hospitals, and had more beds and better operating margins (Table) ; participants were less likely to be safety-net hospitals. Eighty-eight hospitals dropped out fully, 150 dropped out partially (for ≥1 condition), and 184 continued without change. Of the hospital-condition pairs, 1387 dropped out (Figure) , ranging by condition from 24% to 83%. Hospitalcondition pair dropout rates were 11.4% (95% CI, 10.3%-12.6%) by 6 months, 28.4% (95% CI, 26.8%-30.1%) by 12 months, 39.9% (95% CI, 38.2%-41.7%) by 18 months, and 47.0% (95% CI, 45.0%-48.9%) by 24 months after enrollment. Dropout varied by hospital type. For example, unadjusted dropout rates were 58.3% for hospital-condition pairs from for-profit hospitals (aOR, 2.17 [95% CI, 0.58-8.19]), 42.5% for nonprofit hospitals (aOR, 1.15 [95% CI, 0.32-4.16]), and 39.1% for public hospitals (reference group, P = .02) (Table) . Higher operating margins were associated with lower odds of dropout.
Discussion | Only 12% of eligible hospitals signed up for BPCI, and dropout was 47%. Differences between participants and nonparticipants, which confirm prior reports, 3 and the high rate of dropout suggest that voluntary models may not have as much potential as hoped to improve quality and reduce costs across the diverse US health care landscape. One potential solution, Medicare's mandatory bundling program, 4 was criticized for imposing undue burden on clinicians, 5 and the cardiac component of the mandatory program was recently cancelled. 6 Other potential solutions include providing greater rewards for participation, which Medicare is pursuing under its new Quality Payment Program, 2 or altering target cost amounts to make it easier for hospitals to achieve savings.
This study has limitations. Only hospital participants were analyzed, and patterns may differ for physician practices. Program performance was not examined because of the recent nature of the program. Why hospitals left the program is unknown and represents an important area for future research.
Patterns of participation and dropout in the BPCI program suggest that for voluntary alternative payment models to have a broad effect on quality and costs of health care, barriers to participation and strategies for retention need to be addressed. 
Active participants
The BPCI Initiative was launched in 2013. The graph presents hospital-condition pairs because hospitals could join for 1 condition in 1 quarter and another in subsequent quarters, and similarly could drop out for each condition independently. a Each quarter began on the first day of the month. It remains curious why exogenous estrogens should reduce the risk of breast cancer, a largely estrogen-sensitive disease. A possible explanation is that the reduced risk of breast cancer in CEE users is the effect of previous bilateral oophorectomy. It is well established that bilateral oophorectomy reduces the risk of breast cancer in women of all ages. 3-5 Although now less common, bilateral oophorectomy was often performed at the time of hysterectomy for benign disease. In the WHI, 39.5% of women randomized to CEE and 42% randomized to placebo had previously undergone bilateral oophorectomy, as well as hysterectomy.
The potential effect of hormone therapy on breast cancer incidence and mortality is of considerable public interest. Can the authors comment on whether there was any difference in incidence or mortality from breast cancer in women with previous bilateral oophorectomy (n = 4049) randomized to CEE or placebo? Can they also comment on whether breast cancer incidence or death in CEE users differed between women who had previously undergone bilateral oophorectomy and those who retained their ovaries?
If the apparent reduction in breast cancer associated with CEE can be attributed to previous bilateral oophorectomy, this has clinical implications for women and their health care pro-fessionals considering the individualized risk and benefits of hormone therapy use.
